We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boasting strong price-competitiveness, Indian pharmaceutical firms specializing
in generic products are increasingly targeting the fast-growing Japanese market.
Torrent Pharmaceuticals Ltd will begin marketing Indian-made generics, including
its mainstay cardiovascular products, in Japan as early as 2008.
